Phosphodiesterase 4 inhibitors for psoriatic arthritis

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To evaluate the benefits and harms of PDE4 inhibitors (e.g., apremilast) for the treatment of PsA.

Guardat en:
Dades bibliogràfiques
Publicat a:Cochrane Database Syst Rev
Autors principals: Zamora, Natalia V, Valerio‐Morales, Ignacio‐Alfredo, Lopez‐Olivo, Maria Angeles, Pan, Xin, Suarez‐Almazor, Maria E
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Ltd 2016
Matèries:
Medicine General & Introductory Medical Sciences
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6457930/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012401
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars